Clinical Trial: Pirfenidone in the Prevention and Treatment of Radiation-Induced Oral Mucositis in nasopharyngeal carcinoma patients: A randomized, controlled, multicenter phase III study (China)

Posted On: 2026-09-11

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Pirfenidone in the Prevention and Treatment of Radiation-Induced Oral Mucositis in nasopharyngeal carcinoma patients: A randomized, controlled, multicenter phase III study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132171

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: Zhejiang Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=273197

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Pirfenidone in the Prevention and Treatment of Radiation-Induced Oral Mucositis in nasopharyngeal carcinoma patients: A randomized, controlled, multicenter phase III study (China)